Discovery of a novel, selective brain penetrant CDK2 inhibitor for targeted cancer therapy

Oct 24

Written By Sergey Kostikov

Download Poster

Sergey Kostikov

ZE74-0282 is a novel JAK2 JH2 domain inhibitor with promising preclinical activity in JAK2V617F mutant diseases